Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.
Tavel, Jorge A
Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. [electronic resource] - PloS one Feb 2010 - e9334 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1932-6203
10.1371/journal.pone.0009334 doi
Adult
Anti-HIV Agents--adverse effects
Atazanavir Sulfate
CD4 Lymphocyte Count
Carbamates--therapeutic use
Drug Administration Schedule
Drug Therapy, Combination
Female
Fever--chemically induced
Furans
HIV Infections--drug therapy
Humans
Interleukin-2--adverse effects
Lopinavir
Male
Nausea--chemically induced
Oligopeptides--therapeutic use
Opportunistic Infections--chemically induced
Organophosphates--therapeutic use
Pyridines--therapeutic use
Pyrimidinones--therapeutic use
Ritonavir--therapeutic use
Sulfonamides--therapeutic use
Treatment Outcome
Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. [electronic resource] - PloS one Feb 2010 - e9334 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1932-6203
10.1371/journal.pone.0009334 doi
Adult
Anti-HIV Agents--adverse effects
Atazanavir Sulfate
CD4 Lymphocyte Count
Carbamates--therapeutic use
Drug Administration Schedule
Drug Therapy, Combination
Female
Fever--chemically induced
Furans
HIV Infections--drug therapy
Humans
Interleukin-2--adverse effects
Lopinavir
Male
Nausea--chemically induced
Oligopeptides--therapeutic use
Opportunistic Infections--chemically induced
Organophosphates--therapeutic use
Pyridines--therapeutic use
Pyrimidinones--therapeutic use
Ritonavir--therapeutic use
Sulfonamides--therapeutic use
Treatment Outcome